Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
  1. 4 Shares withheld for taxes Chief Financial Officer gave up 48,028 shares (to pay taxes)
  2. 4 Planned sale Director sold 40,000 shares at $3.10 ($124,000)
  3. 4 Planned sale Director sold 30,000 shares at $3.10 ($93,000)
  4. 4 Grant or award Director acquired 4,902 shares (grant or award)
  5. 4 Grant or award Director acquired 3,268 shares (grant or award)
  6. 4 Planned sale Director sold 40,000 shares at $3.25 ($130,000)
  7. 4 Planned sale Chief Financial Officer sold 7,956 shares at $3.39 ($26,971)
  8. 4 Conversion Director acquired 20,000 shares (conversion)
  9. 4 Planned sale CEO and President sold 28,298 shares at $3.35 ($94,660)
  10. 4 Planned sale Director sold 170,000 shares at $3.46 ($588,200)
  11. 4 Shares withheld for taxes Chief Scientific Officer gave up 11,908 shares (to pay taxes)
  12. 4 Planned sale Director sold 40,000 shares at $3.46 ($138,400)
  13. 4 Planned sale Chief Financial Officer sold 13,426 shares at $3.08 ($41,352)
  14. 4 Shares withheld for taxes CEO and President gave up 14,280 shares (to pay taxes)
  15. 4 Shares withheld for taxes CEO and President gave up 10,364 shares (to pay taxes)
  16. 4 Shares withheld for taxes Chief Financial Officer gave up 11,400 shares (to pay taxes)
  17. 4 Shares withheld for taxes Chief Scientific Officer gave up 11,400 shares (to pay taxes)
  18. 4 Planned sale Director sold 40,000 shares at $4.12 ($164,800)
  19. 4 Planned sale Director sold 220,000 shares at $4.20 ($924,000)
  20. 4 Planned sale Director sold 40,000 shares at $4.47 ($178,800)

Page 3 of 26 · 512 filings